Global Recombinant Hepatitis B Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Hepatitis B Vaccine Segment by Type

2.2.1 10mcg/ml

2.2.2 10mcg/0.5ml

2.3 Recombinant Hepatitis B Vaccine Sales by Type

2.3.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Type (2017-2022)

2.4 Recombinant Hepatitis B Vaccine Segment by Application

2.4.1 Newborn

2.4.2 Primary School Students

2.4.3 Adult

2.5 Recombinant Hepatitis B Vaccine Sales by Application

2.5.1 Global Recombinant Hepatitis B Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Hepatitis B Vaccine Sale Price by Application (2017-2022)

3 Global Recombinant Hepatitis B Vaccine by Company

3.1 Global Recombinant Hepatitis B Vaccine Breakdown Data by Company

3.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Company (2020-2022)

3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Company

3.4 Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Hepatitis B Vaccine Product Location Distribution

3.4.2 Players Recombinant Hepatitis B Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Hepatitis B Vaccine by Geographic Region

4.1 World Historic Recombinant Hepatitis B Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Geographic Region

4.2 World Historic Recombinant Hepatitis B Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Country/Region

4.3 Americas Recombinant Hepatitis B Vaccine Sales Growth

4.4 APAC Recombinant Hepatitis B Vaccine Sales Growth

4.5 Europe Recombinant Hepatitis B Vaccine Sales Growth

4.6 Middle East & Africa Recombinant Hepatitis B Vaccine Sales Growth

5 Americas

5.1 Americas Recombinant Hepatitis B Vaccine Sales by Country

5.1.1 Americas Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)

5.1.2 Americas Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)

5.2 Americas Recombinant Hepatitis B Vaccine Sales by Type

5.3 Americas Recombinant Hepatitis B Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Hepatitis B Vaccine Sales by Region

6.1.1 APAC Recombinant Hepatitis B Vaccine Sales by Region (2017-2022)

6.1.2 APAC Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022)

6.2 APAC Recombinant Hepatitis B Vaccine Sales by Type

6.3 APAC Recombinant Hepatitis B Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Hepatitis B Vaccine by Country

7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)

7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)

7.2 Europe Recombinant Hepatitis B Vaccine Sales by Type

7.3 Europe Recombinant Hepatitis B Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Hepatitis B Vaccine by Country

8.1.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type

8.3 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine

10.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine

10.4 Industry Chain Structure of Recombinant Hepatitis B Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Hepatitis B Vaccine Distributors

11.3 Recombinant Hepatitis B Vaccine Customer

12 World Forecast Review for Recombinant Hepatitis B Vaccine by Geographic Region

12.1 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region

12.1.1 Global Recombinant Hepatitis B Vaccine Forecast by Region (2023-2028)

12.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Hepatitis B Vaccine Forecast by Type

12.7 Global Recombinant Hepatitis B Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Recombinant Hepatitis B Vaccine Product Offered

13.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 GlaxoSmithKline Plc

13.2.1 GlaxoSmithKline Plc Company Information

13.2.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Offered

13.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Plc Main Business Overview

13.2.5 GlaxoSmithKline Plc Latest Developments

13.3 Pfizer Inc.

13.3.1 Pfizer Inc. Company Information

13.3.2 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Offered

13.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Inc. Main Business Overview

13.3.5 Pfizer Inc. Latest Developments

13.4 Sanofi Pasteur

13.4.1 Sanofi Pasteur Company Information

13.4.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Offered

13.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Pasteur Main Business Overview

13.4.5 Sanofi Pasteur Latest Developments

13.5 CSL Limited

13.5.1 CSL Limited Company Information

13.5.2 CSL Limited Recombinant Hepatitis B Vaccine Product Offered

13.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CSL Limited Main Business Overview

13.5.5 CSL Limited Latest Developments

13.6 Emergent Biosolutions

13.6.1 Emergent Biosolutions Company Information

13.6.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Offered

13.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Emergent Biosolutions Main Business Overview

13.6.5 Emergent Biosolutions Latest Developments

13.7 Serum Institute of India

13.7.1 Serum Institute of India Company Information

13.7.2 Serum Institute of India Recombinant Hepatitis B Vaccine Product Offered

13.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Serum Institute of India Main Business Overview

13.7.5 Serum Institute of India Latest Developments

13.8 Johnson & Johnson

13.8.1 Johnson & Johnson Company Information

13.8.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Offered

13.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Johnson & Johnson Main Business Overview

13.8.5 Johnson & Johnson Latest Developments

13.9 Hualan Biological Engineering

13.9.1 Hualan Biological Engineering Company Information

13.9.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Offered

13.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hualan Biological Engineering Main Business Overview

13.9.5 Hualan Biological Engineering Latest Developments

13.10 NCPC

13.10.1 NCPC Company Information

13.10.2 NCPC Recombinant Hepatitis B Vaccine Product Offered

13.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 NCPC Main Business Overview

13.10.5 NCPC Latest Developments

13.11 China National Biotec Group

13.11.1 China National Biotec Group Company Information

13.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Product Offered

13.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 China National Biotec Group Main Business Overview

13.11.5 China National Biotec Group Latest Developments

13.12 Dalian Hissen Bio-pharm

13.12.1 Dalian Hissen Bio-pharm Company Information

13.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Offered

13.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Dalian Hissen Bio-pharm Main Business Overview

13.12.5 Dalian Hissen Bio-pharm Latest Developments

13.13 Beijing Tiantan Biological

13.13.1 Beijing Tiantan Biological Company Information

13.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Offered

13.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Beijing Tiantan Biological Main Business Overview

13.13.5 Beijing Tiantan Biological Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 10mcg/ml

Table 4. Major Players of 10mcg/0.5ml

Table 5. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Recombinant Hepatitis B Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022)

Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Recombinant Hepatitis B Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Recombinant Hepatitis B Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Recombinant Hepatitis B Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution and Sales Area

Table 21. Players Recombinant Hepatitis B Vaccine Products Offered

Table 22. Recombinant Hepatitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Recombinant Hepatitis B Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Recombinant Hepatitis B Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Recombinant Hepatitis B Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Recombinant Hepatitis B Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Recombinant Hepatitis B Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Recombinant Hepatitis B Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Recombinant Hepatitis B Vaccine

Table 66. Key Market Challenges & Risks of Recombinant Hepatitis B Vaccine

Table 67. Key Industry Trends of Recombinant Hepatitis B Vaccine

Table 68. Recombinant Hepatitis B Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Recombinant Hepatitis B Vaccine Distributors List

Table 71. Recombinant Hepatitis B Vaccine Customer List

Table 72. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Recombinant Hepatitis B Vaccine Sales Market Forecast by Region

Table 74. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Recombinant Hepatitis B Vaccine Product Offered

Table 94. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. GlaxoSmithKline Plc Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Offered

Table 99. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GlaxoSmithKline Plc Main Business

Table 101. GlaxoSmithKline Plc Latest Developments

Table 102. Pfizer Inc. Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Offered

Table 104. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Pfizer Inc. Main Business

Table 106. Pfizer Inc. Latest Developments

Table 107. Sanofi Pasteur Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Offered

Table 109. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Sanofi Pasteur Main Business

Table 111. Sanofi Pasteur Latest Developments

Table 112. CSL Limited Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. CSL Limited Recombinant Hepatitis B Vaccine Product Offered

Table 114. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. CSL Limited Main Business

Table 116. CSL Limited Latest Developments

Table 117. Emergent Biosolutions Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Offered

Table 119. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Emergent Biosolutions Main Business

Table 121. Emergent Biosolutions Latest Developments

Table 122. Serum Institute of India Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Serum Institute of India Recombinant Hepatitis B Vaccine Product Offered

Table 124. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Serum Institute of India Main Business

Table 126. Serum Institute of India Latest Developments

Table 127. Johnson & Johnson Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Offered

Table 129. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Johnson & Johnson Main Business

Table 131. Johnson & Johnson Latest Developments

Table 132. Hualan Biological Engineering Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Offered

Table 134. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Hualan Biological Engineering Main Business

Table 136. Hualan Biological Engineering Latest Developments

Table 137. NCPC Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. NCPC Recombinant Hepatitis B Vaccine Product Offered

Table 139. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. NCPC Main Business

Table 141. NCPC Latest Developments

Table 142. China National Biotec Group Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. China National Biotec Group Recombinant Hepatitis B Vaccine Product Offered

Table 144. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. China National Biotec Group Main Business

Table 146. China National Biotec Group Latest Developments

Table 147. Dalian Hissen Bio-pharm Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 148. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Offered

Table 149. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Dalian Hissen Bio-pharm Main Business

Table 151. Dalian Hissen Bio-pharm Latest Developments

Table 152. Beijing Tiantan Biological Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 153. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Offered

Table 154. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Beijing Tiantan Biological Main Business

Table 156. Beijing Tiantan Biological Latest Developments

List of Figures

Figure 1. Picture of Recombinant Hepatitis B Vaccine

Figure 2. Recombinant Hepatitis B Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Hepatitis B Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Hepatitis B Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 10mcg/ml

Figure 10. Product Picture of 10mcg/0.5ml

Figure 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2021

Figure 12. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Recombinant Hepatitis B Vaccine Consumed in Newborn

Figure 14. Global Recombinant Hepatitis B Vaccine Market: Newborn (2017-2022) & (K Units)

Figure 15. Recombinant Hepatitis B Vaccine Consumed in Primary School Students

Figure 16. Global Recombinant Hepatitis B Vaccine Market: Primary School Students (2017-2022) & (K Units)

Figure 17. Recombinant Hepatitis B Vaccine Consumed in Adult

Figure 18. Global Recombinant Hepatitis B Vaccine Market: Adult (2017-2022) & (K Units)

Figure 19. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application in 2021

Figure 21. Recombinant Hepatitis B Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Recombinant Hepatitis B Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine

Figure 65. Industry Chain Structure of Recombinant Hepatitis B Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles